Cardlytics, Inc. (CDLX) News
Filter CDLX News Items
CDLX News Results
|Loading, please wait...|
CDLX News Highlights
- CDLX's 30 day story count now stands at 17.
- Over the past 27 days, the trend for CDLX's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- BASE, NICK and NOTE are the most mentioned tickers in articles about CDLX.
Latest CDLX News From Around the Web
Below are the latest news stories about CARDLYTICS INC that investors may wish to consider to help them evaluate CDLX as an investment opportunity.
In her upcoming position at Valor Ventures, Lynn Laube hopes to help grow Atlanta’s venture capital ecosystem with her experience and insight.
In last trading session, Cardlytics Inc. (NASDAQ:CDLX) saw 0.41 million shares changing hands with its beta currently measuring 2.01. Company’s recent per share price level of $4.07 trading at $0.14 or 3.56% at ring of the bell on the day assigns it a market valuation of $149.21M. That closing price of CDLX’s stock is at … With 14.0% Distance From Low, Is Cardlytics Inc. (NASDAQ:CDLX) Poised For More Gains? Read More »
The share price of Cardlytics Inc. (NASDAQ:CDLX) fell to $4.07 per share on Friday from $4.50. While Cardlytics Inc. has underperformed by -9.56%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CDLX fell by -94.61%, with highs and lows ranging from $83.54 to $3.50, whereas the […]
Scott Grimes and Lynn Laube, co-founders who previously served as its CEO at different times, resigned from their positions on Nov. 11. The company also made 51 layoffs to reduce operating costs and focus on growth.
The share price of Cardlytics Inc. (NASDAQ:CDLX) rose to $6.02 per share on Friday from $4.89. While Cardlytics Inc. has overperformed by 23.11%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CDLX fell by -92.96%, with highs and lows ranging from $91.15 to $3.50, whereas the […]
On Wednesday, November 9, Cardlytics (NASDAQ: CDLX) shares dropped by over 10%, continuing their ongoing downtrend.
Cardlytics (NASDAQ: CDLX) shares extended their current negative trend on Wednesday, November 9, dropping by more than 10% as bears… Continue reading The post Cardlytics (CDLX) stock drops over 10% as short interest increases appeared first on Finbold .
Cardlytics''s (NASDAQ: CDLX ) short percent of float has risen 4.17% since its last report. The company recently reported that it has 4.53 million shares sold short , which is 19.72% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.7 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com
After losing some value lately, a hammer chart pattern has been formed for Cardlytics (CDLX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
According to Benzinga Pro, during Q3, Cardlytics (NASDAQ: CDLX ) earned $6.27 million, a 104.96% increase from the preceding quarter. Cardlytics''s sales decreased to $72.71 million, a 3.58% change since Q2. Cardlytics collected $75.41 million in revenue during Q2, but reported earnings showed a $126.29 million loss. What Is Return On Capital Employed? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher … Full story available on Benzinga.com